SCHEMBL26850357

SCHEMBL26850357

CC(C(=O)O)C(C)c1ccncc1C(=O)O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4C Q9H3R0 15/20 0.44
KDM6B O15054 6/20 0.44
KDM4D Q6B0I6 3/20 0.43
TDP1 Q9NUW8 2/20 0.43
KDM4E B2RXH2 2/20 0.43
KDM4A O75164 2/20 0.43
ALDH1A1 P00352 2/20 0.43
MEN1 O00255 1/20 0.43
MAPT P10636 1/20 0.43
THRB P10828 1/20 0.43
KMT2A Q03164 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
SIRT3 Q9NTG7 1/20 0.39
TGFBR1 P36897 1/20 0.36
LMNA P02545 1/20 0.35
NAPRT Q6XQN6 1/20 0.34
APP P05067 1/20 0.34
GAA P10253 1/20 0.34
HCAR3 P49019 1/20 0.34
HCAR2 Q8TDS4 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30716135 1.00 KDM4C (0.44) KDM4CKDM6BKDM4DTDP1KDM4E
SCHEMBL30716134 1.00 KDM4C (0.44) KDM4CKDM6BKDM4DTDP1KDM4E
SCHEMBL26850305 0.87 TDP1 (0.37) KDM4CKDM6BKDM4DTDP1KDM4E
SCHEMBL4582070 0.82 KDM4C (0.50) KDM4CKDM6BKDM4DTDP1KDM4E
Hydrochloric Acid SCHEMBL5740286 0.81 KDM4C (0.49) KDM4CKDM6BKDM4DTDP1KDM4E
SCHEMBL20462852 0.79 KDM4C (0.46) KDM4CKDM6BKDM4DTDP1KDM4E
SCHEMBL20053816 0.77 KDM4C (0.48) KDM4CKDM6BKDM4DTDP1KDM4E
SCHEMBL3932429 0.75 KDM4C (0.48) KDM4CKDM6BKDM4DTDP1KDM4E
SCHEMBL30716132 0.73 KDM4C (0.41) KDM4CKDM6BKDM4DTDP1KDM4E
SCHEMBL30716141 0.73 KDM4C (0.41) KDM4CKDM6BKDM4DTDP1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117637186-A Method for screening and preparing active molecule group in tripterygium plants and application thereof 重庆市中药研究院 2024-03-01 CN claimed
CN-117338831-A Low-toxicity tripterygium wilfordii extract and preparation method and application thereof 重庆市中药研究院 2024-01-05 CN claimed
US-20230372323-A1 Nicotinic Acid Derivative A With Anti-Inflammation and Anti-Platelet Aggregation Activities, and Use Thereof CHONGQING ACADEMY OF CHINESE MATERIA MEDICA (CN) 2023-11-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230372323-A1 Nicotinic Acid Derivative A With Anti-Inflammation and Anti-Platelet Aggregation Activities, and Use Thereof NAPRT, P2RY1, P2RY10 KDM4C 4816/4885KDM6B 4159/4885KDM4D 4819/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.